We do not know how severe the covid-19 epidemic will be or how much economic and social pain it will cause, but it clearly has the potential to kill hundreds of thousands or even millions of Americans, and the economic consequences could include a deep recession and even a financial crisis that will cause misery to tens of millions of people. Testing is key to getting the epidemic under control, and it is not clear to me that policymakers are being nearly...
Read More »Remdesivir II
This is, in fact, another post on Coronavirus, but it will take me a while to get to the point. To put the conclusion here, I think that it is important to get the FDA out of the way (by executive order if necessary). The Food and Drug Act, as currently interpreted, requires the assumption that people should (generally) not be treated with pharmaceuticals which haven’t been proven to be safe and effective. The rule is first do no harm, second do no harm....
Read More »To Slow Spread Of Coronovirus, End Iran Sanctions
To Slow Spread Of Coronovirus, End Iran Sanctions On 3/13/20 in Foreign Policy Focus, Ariel Gold and Medea Benjamin argue that to improve the global coronavirus problem, sanctions on Iran should be lifted, quite aside from the fact they should never have been imposed in the first place as Iran was adhering to the JCPOA nuclear deal. The effect of the sanctions has been to tank the Iranian economy, including its health care sector, much worsening the...
Read More »Shelter in place
The San Francisco Chronicle reports “shelter in place” restrictions. My daughter lives in Santa Clara county, where schools are closed till April 13. Six Bay Area counties announced a “shelter in place” order for all residents on Monday — the strictest measure of its kind in the country — directing everyone to stay inside their homes and away from others as much as possible for the next three weeks as public health officials desperately try to curb the...
Read More »Reporting from Germany: “Welt am Sonntag”
Welt am Sonntag is reporting our honorable President is attempting to bribe lure a German company CureVac to develop a vaccine to be used only in the US. Germany’s Health Ministry confirmed a report in the newspaper “Welt am Sonntag”, which said President Donald Trump had offered bribes funds to lure the German company CureVac to the United States, and the German government was making counter-offers to tempt it to stay. Welt am Sonntag quoted an...
Read More »Europe’s Response to Coronavirus and the Implications for the U.S.
Europe’s Response to Coronavirus and the Implications for the U.S. As I listened to the morning news about the coronavirus crisis, I was reminded of this critique of the Eurozone: In a recent conference, the distinguished economist Paul Krugman repeated the oft-heard critique that the eurozone is not an optimal currency area. Waltraud Schelkle disagrees with this characterisation, and argues that no country or group of countries represents an optimal...
Read More »Benefit-Cost Analysis and the Coronavirus
Benefit-Cost Analysis and the Coronavirus We are in the middle of a flurry of decision-making on how to deal with COVID-19. After much resistance, officials are now canceling public events, closing schools and discouraging other activities that put us in contact with each other. Travel restrictions and possible shutdowns of workplaces, as we’ve seen in Italy, may be up next. It’s interesting we haven’t heard anything about benefit-cost analysis in...
Read More »Three related metrics of coronavirus
Three related metrics of coronavirus Here are three different but ultimately related updates about the coronavirus pandemic. 1. It is 100x more lethal than the 2009 H1N1 swine flu The latest right-wing disinformation is that Obama waited 6 months to declare the 2009 swine flu an emergency, and 1000 people died. As others have pointed out, his Secretary of Health and Human Services did so only 11 days into the US outbreak. So why don’t we remember a big...
Read More »Coronavirus update: reason for alarm; (small) reason for hope
Coronavirus update: reason for alarm; (small) reason for hope This weekend has continued the discouraging news: reports just about everywhere that the Young Invulnerables packed the bars Friday night; the Petri dishes of airport security lines packed with Americans returning from Europe; and personally, two friends who I have known for almost 40 years getting very sick this past week and not able to be tested for coronavirus (one of whom by the way went...
Read More »Coronavirus Treatment Case Report
“First Case of 2019 Novel Coronavirus in the United States” Holshue et al 2020 I quote Treatment with intravenous remdesivir (a novel nucleotide analogue prodrug in development10,11) was initiated on the evening of day 7, and no adverse events were observed in association with the infusion. Vancomycin was discontinued on the evening of day 7, and cefepime was discontinued on the following day, after serial negative procalcitonin levels and negative nasal...
Read More »